SE7700500L - Tiazolidinderivat och forfarande for deras framstellning - Google Patents

Tiazolidinderivat och forfarande for deras framstellning

Info

Publication number
SE7700500L
SE7700500L SE7700500A SE7700500A SE7700500L SE 7700500 L SE7700500 L SE 7700500L SE 7700500 A SE7700500 A SE 7700500A SE 7700500 A SE7700500 A SE 7700500A SE 7700500 L SE7700500 L SE 7700500L
Authority
SE
Sweden
Prior art keywords
procedures
preparation
thiazolidine derivatives
thiazolidine
derivatives
Prior art date
Application number
SE7700500A
Other languages
English (en)
Swedish (sv)
Inventor
H-J Lang
R Muschaweck
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication date
Publication of SE7700500L publication Critical patent/SE7700500L/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30Oxygen or sulfur atoms
    • C07D233/42Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/16Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
SE7700500A 1976-01-20 Tiazolidinderivat och forfarande for deras framstellning SE7700500L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762601791 DE2601791A1 (de) 1976-01-20 1976-01-20 Thiazolidinderivate und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
SE7700500L true SE7700500L (sv) 1977-07-21

Family

ID=5967727

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7700500A SE7700500L (sv) 1976-01-20 Tiazolidinderivat och forfarande for deras framstellning

Country Status (20)

Country Link
US (1) US4129656A (es)
JP (1) JPS5289669A (es)
AT (1) AT356102B (es)
AU (1) AU511547B2 (es)
BE (1) BE850575A (es)
CA (1) CA1078847A (es)
DE (1) DE2601791A1 (es)
DK (1) DK19777A (es)
ES (4) ES455013A1 (es)
FI (1) FI770142A (es)
FR (1) FR2338937A1 (es)
GB (1) GB1541974A (es)
HU (1) HU175096B (es)
IE (1) IE44213B1 (es)
IL (1) IL51287A (es)
IT (1) IT1077590B (es)
LU (1) LU76597A1 (es)
NL (1) NL7700381A (es)
NO (1) NO770161L (es)
SE (1) SE7700500L (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2737195A1 (de) * 1977-08-18 1979-03-01 Hoechst Ag Benzolsulfonamidderivate und verfahren zu ihrer herstellung
DE19731782A1 (de) * 1997-07-24 1999-01-28 Bayer Ag Verfahren zur Herstellung von Pyridylmethylisocyanaten
DE19908539A1 (de) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Polycyclische 2-Amino-Dihydrothiazolsysteme, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE10008274A1 (de) * 2000-02-23 2001-08-30 Aventis Pharma Gmbh Substituierte 8,8a-Dihydro-3aH-indeno[1,2-d]thiazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE10142665B4 (de) * 2001-08-31 2004-05-06 Aventis Pharma Deutschland Gmbh C2-Disubstituierte Indan-1-one und ihre Derivate
DE10142722A1 (de) * 2001-08-31 2003-03-27 Aventis Pharma Deutschland GmbH, 65929 Frankfurt C2-substituierte Indan-1-one und ihre Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US7271195B2 (en) * 2003-06-10 2007-09-18 Kalypsys, Inc. Carbonyl compounds as inhibitors of histone deacetylase for the treatment of disease
BRPI0411275A (pt) * 2003-06-10 2006-08-01 Kalypsys Inc compostos de carbonila como inibidores de histona deacetilase para tratamento de doenças; composição farmacêutica; método de modular a atividade catalìtica de hdac; método de tratar doença em um indivìduo; utilização de um composto ou composição; método de inibir hdac
EP1773398A2 (en) * 2004-06-10 2007-04-18 Kalypsys, Inc. Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease
EP2202222A3 (en) * 2005-11-08 2010-09-15 Laboratorios Del Dr. Esteve, S.A. Indene derivatives, their preparation and use as medicaments
EP1884515A1 (en) * 2006-07-31 2008-02-06 Laboratorios del Dr. Esteve S.A. Substituted indanyl sulfonamide compounds, their preparation and use as medicaments
US10392381B2 (en) 2014-07-18 2019-08-27 Ohio University Prevention and treatment of non-alcoholic fatty liver disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3671534A (en) * 1970-03-16 1972-06-20 Sandoz Ag 6,6-DI-LOWER ALKYL-2,3,5,6-TETRAHYDROIMIDAZO {8 2,1-b{9 {11 THIAZOLES
DE2546165A1 (de) * 1975-10-15 1977-04-28 Hoechst Ag Thiazolidinderivate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
GB1541974A (en) 1979-03-14
HU175096B (hu) 1980-05-28
ATA28277A (de) 1979-09-15
FR2338937B1 (es) 1980-03-28
DK19777A (da) 1977-07-21
LU76597A1 (es) 1977-07-27
BE850575A (fr) 1977-07-20
DE2601791A1 (de) 1977-07-21
AU2143377A (en) 1978-07-27
JPS5289669A (en) 1977-07-27
IL51287A (en) 1980-05-30
AT356102B (de) 1980-04-10
IT1077590B (it) 1985-05-04
IE44213L (en) 1977-07-20
US4129656A (en) 1978-12-12
ES475558A1 (es) 1979-05-16
NL7700381A (nl) 1977-07-22
IL51287A0 (en) 1977-03-31
ES475559A1 (es) 1979-05-01
FI770142A (es) 1977-07-21
ES475557A1 (es) 1979-05-01
ES455013A1 (es) 1979-05-01
FR2338937A1 (fr) 1977-08-19
NO770161L (no) 1977-07-21
IE44213B1 (en) 1981-09-09
CA1078847A (en) 1980-06-03
AU511547B2 (en) 1980-08-21

Similar Documents

Publication Publication Date Title
SE7803660L (sv) Cefemderivat och forfarande for deras framstellning
SE7804185L (sv) Cefemderivat och forfarande for deras framstellning
SE7710084L (sv) Tiazolidinderivat och forfarande for deras framstellning
SE7802853L (sv) Cefemderivat och forfarande for deras framstellning
NO774126L (no) Fremgangsmaate for fremstilling av tiazolidin- og tiazanderivater
SE7603554L (sv) Nitrofurylpyrazolderivat och sett for deras framstellning
SE7700500L (sv) Tiazolidinderivat och forfarande for deras framstellning
SE7709942L (sv) Uracilderivat och forfarande for framstellning derav
SE7708121L (sv) Peptidderivat och forfarande for deras framstellning
SE7810312L (sv) Fenylisotiocyanatderivat och framstellning derav
SE7709333L (sv) Dihydro-oxo-nikotinsyror och forfarande for deras framstellning
SE7705873L (sv) Bensensulfonykarbamider och forfarande for deras framstellning
SE7605500L (sv) Antrakinon-bis-amidiner och forfarande for deras framstellning
SE7708379L (sv) Peptidderivat och forfarande for framstellning derav
SE7611504L (sv) Tiazolidinderivat och forfarande for deras framstellning
SE7605069L (sv) 14beta-hydroxy 3-deoxikardenolider och forfarande for deras framstellning
SE432424B (sv) Halogenerade alkoxisilanforeningar och forfarande for deras framstellning
SE7706269L (sv) Uracilderivat och forfarande for framstellning derav
SE7713958L (sv) Bensimidazolderivat och sett for deras framstellning
SE7805874L (sv) 1-fenyl-1-metoxi-2-amino-etanderivat och forfarande for framstellning derav
SE7700436L (sv) Tiazolidinderivat och forfarande for deras framstellning
SE7600704L (sv) Difenyleter-derivat och forfarande for framstellning derav
SE7708120L (sv) Peptidderivat och forfarande for deras framstellning
SE7712725L (sv) Kinolonderivat och forfarande for framstellning derav
SE7813183L (sv) Naftalenderivat och sett for deras framstellning